Session » Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II: Extra-MSK & Comorbidities

Date: Sunday, November 8, 2020

Time: 9:00AM-11:00AM

Meeting: ACR Convergence 2020

9:00AM-11:00AM: Abstract Number: 1317

A Large Agreement Between the Pain Points of the ACR 1990 Fibromyalgia Criteria and the MASES Enthesitis Score Is Observed in Patients with Axial Spondylitis, Including in Patients Without Concomitant Fibromyalgia

9:00AM-11:00AM: Abstract Number: 1333

Ankylosing Spondylitis Patients at Risk of Developing Aortic Valve Regurgitation, Need for Mandatory Echocardiography?

9:00AM-11:00AM: Abstract Number: 1320

Are Coping Strategies, Anxiety and Depression Associated with Daily Physical Activity in Patient with Axial SpA?

9:00AM-11:00AM: Abstract Number: 1336

Bone Mineral Density, Trabecular Bone Score and Proximal Femur 3D-DXA Analysis in Psoriatic Diseases

9:00AM-11:00AM: Abstract Number: 1328

Cardiac Biomarkers Are Associated with the Development of Cardiovascular Events in Patients with Psoriatic Arthritis and Psoriasis

9:00AM-11:00AM: Abstract Number: 1331

Carotid Ultrasound Findings in Psoriatic Arthritis: A Case-control Study

9:00AM-11:00AM: Abstract Number: 1318

Catastrophizing in Patients with Axial Spondyloarthritis and Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 1321

Central Sensitization, Disease Perception and Obesity Should Be Taken into Account When Interpreting Disease Activity in Patients with Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1327

Comorbidity Burden in Patients with Non-Radiographic Axial Spondyloarthritis at Least as High as in Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1339

COVID-19 in Patients with Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and DMARDs on Clinical Outcomes

9:00AM-11:00AM: Abstract Number: 1307

Detecting Subtle Changes in Fundoscopic Retinal Images in Patients with Axial Spondyloarthritis with Deep Learning

9:00AM-11:00AM: Abstract Number: 1319

Disease Activity and Mental Health of as Patients: A Cross-section Study with Self-assessments Based on Smart System of Disease Management (SSDM) Mobile Tools

9:00AM-11:00AM: Abstract Number: 1334

Does Interstitial Lung Disease Represent a Real Comorbidity in Spondyloarthritis Patients? Results from an Ultrasound, Monocentric, Pilot Study

9:00AM-11:00AM: Abstract Number: 1315

Exploring the Prevalence and Factors Associated with Fatigue in Axial Spondyloarthritis in a Multiethnic Asian Cohort in Singapore

9:00AM-11:00AM: Abstract Number: 1314

Fatigue in Psoriatic Arthritis (PsA): Prevalence in Patients from the US and Europe, and Impact on Quality of Life and Work Productivity

9:00AM-11:00AM: Abstract Number: 1310

Gut Microbiome Changes Are Different Between Ankylosing Spondylitis and Inflammatory Bowel Disease, and Correlate with Disease Activity in Both Diseases

9:00AM-11:00AM: Abstract Number: 1306

High Prevalence of Previously Undiagnosed Axial Spondyloarthritis in Patients Referred with Anterior Uveitis and Chronic Back Pain

9:00AM-11:00AM: Abstract Number: 1311

Identification of Clinical Phenotypes in Patients with Axial Spondyloarthritis, Peripheral Spondyloarthritis and Psoriatic Arthritis According to Peripheral Musculoskeletal Manifestations: A Cluster Analysis in the International ASAS-PerSpA Study

9:00AM-11:00AM: Abstract Number: 1338

Identification of Muscle Associated Key Genes to Support Axial Spondyloarthritis Diagnosis by Transcriptomic Approach, the MyoSpA Study

9:00AM-11:00AM: Abstract Number: 1332

Identifying the as Patient at Risk: Is Aortic Root Diameter Associated with HLA-B27?

9:00AM-11:00AM: Abstract Number: 1305

Is the Occurrence of Acute Anterior Uveitis Linked Primarily to Ankylosing Spondylitis (AS) or to HLA-B27? Results of a 35-Year Follow-Up Family Study of a Swiss Cohort of Patients with AS

9:00AM-11:00AM: Abstract Number: 1326

Malignancy Risk Among Patients with Ankylosing Spondylitis in the United States: A Population-Based National Study

9:00AM-11:00AM: Abstract Number: 1325

Monoclonal Gammopathy in Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 1316

Patient Perceptions of Fibromyalgia Symptoms and the Overlap with Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1303

Performance of Three Referral Algorithms for Diagnosing Axial Spondyloarthritis: Results from the Screening in Axial Spondyloarthritis for Psoriasis, Iritis, and Colitis Cohort

9:00AM-11:00AM: Abstract Number: 1323

Pregnancy in Axial Spondyloarthropathy: A Systematic Review & Meta-Analysis

9:00AM-11:00AM: Abstract Number: 1322

Prevalence and Associated Factors of Sleep Disorders in Patients with Axial Spondyloarthritis. Results from the European Map of Axial Spondyloarthritis (EMAS)

9:00AM-11:00AM: Abstract Number: 1313

Prevalence of Extra-Articular Manifestations in Early Ankylosing Spondylitis versus Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Meta-Analysis of 1504 Patients

9:00AM-11:00AM: Abstract Number: 1309

Prevalence of Undiagnosed Axial Spondyloarthritis Among Patients with Inflammatory Bowel Disease: A Secondary Care Cross-Sectional Study

9:00AM-11:00AM: Abstract Number: 1337

Relationship of the Pro12Ala Polymorphism of the PPARg Gene with Inflammatory Activity, Osteoporosis and Obesity in Patients with Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 1324

Risk Factors for Adverse Pregnancy Outcomes in Women with Spondyloarthritis: An Observational Study from Two European Multidisciplinary Pregnancy Clinics

9:00AM-11:00AM: Abstract Number: 1335

Smoking, but Not Use of Complementary and Alternative Medicine Predicts Residual Functional Disability in Patients with Inflammatory Arthritis on Biologic Disease Modifying Anti-Rheumatic Drugs: Results from the Singapore National Biologics Register

9:00AM-11:00AM: Abstract Number: 1329

Subclinical Atherosclerosis Risk in Psoriatic Arthritis: Could It Be Prevented?

9:00AM-11:00AM: Abstract Number: 1330

Subclinical atherosclertoic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study with 806 patients.

9:00AM-11:00AM: Abstract Number: 1308

The Presence of Spondyloarthritis Is Associated with Higher Clinical Disease Activity in Patients with Early Crohn’s Disease: Results of a Prospective Cohort Study

9:00AM-11:00AM: Abstract Number: 1312

Time-dependent Analysis of Incident Extra-articular Manifestations and Comorbidities in Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1304

Uveitis Occurrence in Early Inflammatory Back Pain: Five Years Data from a Prospective French Nationwide Cohort

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].